Table 1.
Study, year | Country | Design | No. of patients, n | Age, years, mean ± SD | Pathological stage classification | Follow-up, month, Mean ± SD | Outcome (Questionnaire) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0-II | ≥III | |||||||||||||
Total | ONB | ICD | ONB | ICD | ONB | ICD | ONB | ICD | ONB | ICD | ||||
Gacci, 2013 (34) | Italy | Cross-sectional study | 25 | 9 | 16 | 71.8 ± 7.0 | 74.4 ± 8.8 | 4 | 13 | 5 | 3 | 60.1 ± 21.5 | EORTC-QLQ-C30, EORTC-QLQ-BLM-30 | |
Zahran, 2017a (35) | Egypt | Cross-sectional study | 43 | 22 | 21 | 61.4 ± 11.2 | 63.3 ± 5.7 | / | / | / | / | / | / | EORTC-QLQ-C30 |
Zahran, 2017b (35) | Egypt | Cross-sectional study | 47 | 27 | 20 | 57 ± 10.3 | 63.3 ± 5.7 | / | / | / | / | / | / | EORTC-QLQ-C30 |
Zahran, 2017c (35) | Egypt | Cross-sectional study | 55 | 35 | 20 | 61.8 ± 6.6 | 63.3 ± 5.7 | / | / | / | / | / | / | EORTC-QLQ-C30 |
Siracusano, 2019 (36) | Italy | Cross-sectional study | 73 | 24 | 49 | 67 ± 10.5 | 73 ± 8.6 | 15 | 29 | 9 | 20 | 43 ± 30.5 | 54 ± 36.8 | EORTC-QLQ-C30, QLQ-BLM-30 |
Biardeau, 2020 (37) | France | Cross-sectional study | 40 | 17 | 23 | 60.0 ± 7 | 71.0 ± 11.8 | 12 | 13 | 5 | 10 | / | / | EORTC-QLQ-C30, EORTC-QLQ-BLM30 |
ICD, ileal conduit diversion; ONB, orthotopic neobladder.